Nirvana Life Sciences (XCNQ:NIRV) Total Liabilities : C$1.03 Mil (As of Jan. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nirvana Life Sciences Total Liabilities?

Nirvana Life Sciences's Total Liabilities for the quarter that ended in Jan. 2024 was C$1.03 Mil.

Nirvana Life Sciences's quarterly Total Liabilities increased from Jul. 2023 (C$0.85 Mil) to Oct. 2023 (C$0.91 Mil) and increased from Oct. 2023 (C$0.91 Mil) to Jan. 2024 (C$1.03 Mil).

Nirvana Life Sciences's annual Total Liabilities increased from Oct. 2021 (C$0.55 Mil) to Apr. 2022 (C$0.65 Mil) and increased from Apr. 2022 (C$0.65 Mil) to Apr. 2023 (C$1.01 Mil).

Nirvana Life Sciences Total Liabilities Historical Data

The historical data trend for Nirvana Life Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nirvana Life Sciences Total Liabilities Chart

Nirvana Life Sciences Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Apr22

Apr23

Total Liabilities

Get a 7-Day Free Trial

0.75

0.53

0.55

0.65

1.01

Nirvana Life Sciences Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Liabilities	Get a 7-Day Free Trial															0.94	1.01	0.85	0.91	1.03

Nirvana Life Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Nirvana Life Sciences's Total Liabilities for the fiscal year that ended in Apr. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.008	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1.01

Total Liabilities	=	Total Assets (A: Apr. 2023 )	-	Total Equity (A: Apr. 2023 )
	=	0.069	-	-0.94
	=	1.01

Nirvana Life Sciences's Total Liabilities for the quarter that ended in Jan. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.029	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1.03

Total Liabilities	=	Total Assets (Q: Jan. 2024 )	-	Total Equity (Q: Jan. 2024 )
	=	0.212	-	-0.817
	=	1.03

Nirvana Life Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Nirvana Life Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nirvana Life Sciences (XCNQ:NIRV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nirvana Life Sciences Inc (XCNQ:NIRV) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8

Website

https://www.nirvanalifescience.com

Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Nirvana Life Sciences (XCNQ:NIRV) Headlines

No Headlines